DarioHealth Launches GLP-1 Program, With Commercial Availability Expected Fall 2026, With Revenue Contribution From Late 2026 And Ramping Through 2027

DarioHealth Corp.
Hims & Hers Health

DarioHealth Corp.

DRIO

0.00

Hims & Hers Health

HIMS

0.00

First commercial offering from Dario's collaboration with Beluga Health adds licensed provider evaluation, prescribing and ongoing clinical oversight directly inside Dario's chronic care platform

Launch addresses a market in which employers and health plans are reducing GLP-1 coverage and members are increasingly accessing care through consumer channels

Available through three channels: Dario's direct-to-consumer shop, health plan marketplaces and employer B2B2C programs